News Note · IDAEO AI News

#News media

09/23《生技股動態》-環球生技月刊

Original-language title

Publisher:

TL;DR · What this means

✔ 安特羅(6564)與泰國Biogenetech簽訂腸病毒疫苗獨家經銷合約

(Excerpt from the original lead, not a rewrite)

Story Text

Full English translation is in progress; the text below is the original.

市場觀測:

✔ 安特羅(6564)與泰國Biogenetech簽訂腸病毒疫苗獨家經銷合約

✔ 鼎晉生技(7876)現增1500萬股案,認股基準日11/1

✔ 鼎晉生技(7876)現增1500萬股案,擬申請每股調整為40元

✔ 基米(4195)營運長張佐維職務調整,由執行長吳尚蕙暫代

09/23一日漲跌

(漲)安克10%、浩鼎9.95%、台新藥9.83%

(跌)天良8.49%、惠光5.34%、台微醫3.94%

https://reurl.cc/90y9AO

09/23 法人動態

(買超)高端疫苗1349張、浩鼎792張、合一639張;

(賣超)漢達679張、康霈*467張、藥華藥452張

https://reurl.cc/AXDlWQ

市場即時觀測:

http://bit.ly/bio-invest

新聞集錦

投資雷達

Citation-ready facts (F-Units)

✔ 安特羅(6564)與泰國Biogenetech簽訂腸病毒疫苗獨家經銷合約

F1 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 2 · news.gbimonthly.com Source type: unclassified (not verified)

✔ 鼎晉生技(7876)現增1500萬股案,認股基準日11/1

F2 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 3 · news.gbimonthly.com Source type: unclassified (not verified)

✔ 鼎晉生技(7876)現增1500萬股案,擬申請每股調整為40元

F3 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 4 · news.gbimonthly.com Source type: unclassified (not verified)

✔ 基米(4195)營運長張佐維職務調整,由執行長吳尚蕙暫代

F4 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 5 · news.gbimonthly.com Source type: unclassified (not verified)

(漲)安克10%、浩鼎9.95%、台新藥9.83%

F5 Original sentence as captured by this site (only formatting marks and extra spaces removed), paragraph 7 · news.gbimonthly.com Source type: unclassified (not verified)

Frequently Asked Questions (FAQ)

這則新聞的重點是什麼?

✔ 安特羅(6564)與泰國Biogenetech簽訂腸病毒疫苗獨家經銷合約

原文提到哪些關鍵數字?

✔ 鼎晉生技(7876)現增1500萬股案,認股基準日11/1 ✔ 鼎晉生技(7876)現增1500萬股案,擬申請每股調整為40元

這則新聞的原始出處與發布時間?

原始出處:news.gbimonthly.com(https://news.gbimonthly.com/tw/invest/show.php?num=90333&kind=20)。原文發布時間:2026-09-23。